Infective Endocarditis
Infective Endocarditis is defined as infection of the endocardial surface of the
heart which might also involve the heart valves. Valves involved in Infective
Endocarditis in descending order of frequency are the mitral valve, followed by aortic valve,
followed by combined involvement of mitral and aortic valves, followed by tricuspid valve and
rarely the pulmonic valve is involved.
The pathomechanism by which Infective Endocarditis is thought to occur is
that, turbulence of blood flow in the heart for instance due to underlying
valvular abnormality is thought to cause injury to the endothelial surface of
the heart, which allows either direct infection of the endocardium or it can
cause development of uninfected platelet/fibrin thrombus (a condition known
as nonbacterial thrombotic endocarditis) and the thrombus might
subsequently serve as a site of bacterial attachment during transient
bacteremia and could end up causing infection of the endocardial surface of
the heart.
Predisposing factors for Infective Endocarditis include:
-Rheumatic heart disease which accounts for about 20%of cases of Infective Endocarditis
-age related degenerative valve disease particularly calcific aortic stenosis accounting for about
50 % of cases of Infective Endocarditis
-congenital heart disease accounts for about 15% of cases of Infective Endocarditis, bicuspid
aortic valve being the commonest congenital heart disease associated with Infective Endocarditis
-residual valve damage from previous episode of endocarditis
-in young adults, the commonest predisposing condition is Mitral Valve Prolapse, accounting for
about 30% of cases of endocarditis in this age group
-assymetric septal hypertrophy involving the mitral valve accounts for about 5% of cases of
Infective Endocarditis
-illicit intravenous drug use
-presence of intracardiac devices for instance pacemaker or defibrillator wire or presence of
artificial (prosthetic) valve
- and presence of intravascular devices for instance central or peripheral intravenous catheters or
presence of hemodialysis shunts or catheters.
Infective endocarditis can be classified into the following five categories:
Minor criteria include, 1- predisposing heart condition or injection drug use 2- fever > 38 degree
centigrade 3- presence of vascular phenomena including, major arterial emboli, septic pulmonary
infarct, mycotic aneurysm, intracerebral hemorrhage because of rupture of mycotic aneurysm,
conjunctival hemorrhage or Janeway lesions, 4- presence of immunologic manifestation
including, glomerulonephritis, Osler nodes, Roth spots or elevation of Rheumatoid factor, 5serologic evidence of active infection with organism consistent with Infective Endocarditis.
Diagnosis is made if there are two major criteria, or one major and three minor criteria or if
there are five minor criteria.
Treatment
In individuals with native valve endocarditis since the commonest cause is Streptococcus
species, empiric treatment is two to four weeks course of Penicillin G and Gentamycin, or one
could administer Ceftriaxone + Gentamycin as Ceftriaxone could also cover Staphylococcus (the
second commonest cause of native valve Infective Endocarditis.)
Gentamycin is added because there could be some degree of resistance to PCN or Ceftriaxone
alone and Gentamycin potentiates the effect of PCN or Ceftriaxone.
If culture and susceptibility report is available and if it yields Streptococcus species and if it is
susceptible to PCN, PCN alone without Gentamycin can be continued. If culture demonstrates
the causative organism to be Staphylococcus and if it is susceptible to Naficillin or Ceftriaxone,
Naficillin or Ceftriaxone alone can be continued without Gentamycin.
If culture and susceptibility report is unavailable and if PCN resistant Streptococcus or
Ceftriaxione resistant Staphylococcus is suspected because of poor response, the PCN or
Ceftriaxone is changed to Vancomycin.
In individuals with prosthetic valve endocarditis or in individuals with pacemaker associated
Infective Endocarditis, since the commonest causes are coagulase negative Staphylococcus and
Staphylococcus Aureus, empiric treatment is with:
Naficillin or Oxacillin or Ceftriaxone for 6-8 weeks
+ Gentamycin for 2 weeks
+ Rifampin for 6-8 weeks
Rifampin is added because it can penetrate the biofilm of most of the pathogens that infect
prosthetic valve or other intracardiac devices, for instance pacemaker wire.
If methicillin resistant Staphylococcus is suspected because of poor response, Naficillin,
Oxacillin or Ceftriaxone is changed to Vancomycin to be administered for 6-8 weeks.
In individuals with history of IV drug use, since commonest cause is Staphylococcus, empiric
treatment is 4-6 weeks course of Naficillin and Gentamycin or Ceftriaxone and Gentamycin.
If methicillin resistant Staphylococcus is suspected because of poor response, the Naficillin or
Ceftriaxone is changed to Vancomycin.
Endocarditis due to HACEK organisms is treated with 4 weeks course of Ceftriaxone or with 4
weeks course of Ampicillin and Gentamycin.
If blood culture is available and if it yields a fungal pathogen, for instance in an individual with
prosthetic valve or in an individual with history of IV drug use, antifungal agents are generally
not effective in eliminating fungal Infective Endocarditis, except in Infective Endocarditis caused
by Histoplasma Capsulatum, therefore in individuals with Infective Endocarditis due to Candida
or Aspergillus species, surgical excision of the involved valve, prosthetic valve replacement and
treatment with Amphoterecin B is indicated.
Other indications for cardiac surgical intervention in individuals with endocarditis include:
1-to remove large vegetation causing stenosis of the affected valve
2-and if there is severe valve regurgitation due to the infectious process causing valve
destruction, one need to do valve repair or one may need to excise the infected valve and implant
prosthetic valve.
3-other indication for surgery is presence of perivalvular abscess and/or intracardiac fistula, in
individuals with perivalvular abscess, one need to surgically drain the abscess, and if there is
intracardiac fistula one need to repair the fistula.
4-and in individuals with prosthetic valve, if the prosthetic valve is detached from the valve ring
and unstable, one need to replace the prosthetic valve.